Filing Details

Accession Number:
0001192482-18-000474
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-13 16:17:41
Reporting Period:
2018-11-07
Accepted Time:
2018-11-13 16:17:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138776 Aevi Genomic Medicine Inc. GNMX Biological Products, (No Disgnostic Substances) (2836) 980217544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304755 Jr J Joseph Grano C/O Aevi Genomic Medicine, Inc.
435 Devon Park Drive, Suite 715
Wayne PA 19087
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-07 26,000 $1.16 75,683 No 4 P Direct
Common Stock Acquisiton 2018-11-07 21,000 $1.17 27,000 No 4 P Indirect By wife
Common Stock Acquisiton 2018-11-07 21,000 $1.15 56,780 No 4 P Indirect By The Grano Children's Trust Robert Silver and Joseph C Grano Trustees
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By wife
No 4 P Indirect By The Grano Children's Trust Robert Silver and Joseph C Grano Trustees
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,384 Indirect By The Grano Family Foundation
Footnotes
  1. The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $1.15 to $1.17, inclusive. The reporting person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Total amount revised to reflect 7,000 shares of common stock incorrectly reported as owned by the reporting person.
  3. Includes 6,000 shares of common stock previously reported as held directly by the reporting person.
  4. Includes 35,780 shares of common stock previously reported as held directly by the reporting person.